Dafna Yahav
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 42
-
- Antimicrobial Resistance in Staphylococcus 22
- SARS-CoV-2 and COVID-19 Research 18
- COVID-19 Clinical Research Studies 15
- Co-authors
- Mical Paul (68 shared papers)Leonard Leibovici (58 shared papers)Jihad Bishara (33 shared papers)Noa Eliakim‐Raz (26 shared papers)Abigail Fraser (6 shared papers)Benaya Rozen Zvi (16 shared papers)Noam Tau (21 shared papers)Elad Goldberg (18 shared papers)
- Journals
- Clinical Microbiology and Infection (47 papers)Clinical Infectious Diseases (22 papers)Journal of Antimicrobial Chemotherapy (17 papers)European Journal of Clinical Microbiology & Infectious Diseases (13 papers)Infectious Diseases and Therapy (13 papers)
- Partner nations
- IsraelItalyUnited States
In The Last Decade
Dafna Yahav
254 papers receiving 8.1k citations
Dafna Yahav's Hit Papers
Peers
Comparison fields: 5 of 164
- Applied Microbiology and Biotechnology 786
- Molecular Medicine 2.1k
- Microbiology 131
- Infectious Diseases 1.9k
- Clinical Biochemistry 638
Countries citing papers authored by Dafna Yahav
This map shows the geographic impact of Dafna Yahav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafna Yahav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafna Yahav more than expected).
Fields of papers citing papers by Dafna Yahav
This network shows the impact of papers produced by Dafna Yahav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafna Yahav. The network helps show where Dafna Yahav may publish in the future.
Co-authors
The 25 scholars most cited alongside Dafna Yahav, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 283 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial Hit paper breakdown → | 2018 | 509 |
| 2 | New β-Lactam–β-Lactamase Inhibitor Combinations Hit paper breakdown → | 2020 | 418 |
| 3 | Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial Hit paper breakdown → | 2018 | 332 |
| 4 | 2013 | 243 | |
| 5 | 2011 | 233 | |
| 6 | 2011 | 225 | |
| 7 | 2008 | 221 | |
| 8 | 2020 | 210 | |
| 9 | 2021 | 207 | |
| 10 | 2007 | 202 | |
| 11 | 2008 | 196 | |
| 12 | 2021 | 174 | |
| 13 | 2005 | 155 | |
| 14 | 2018 | 155 | |
| 15 | 2020 | 147 | |
| 16 | 2010 | 141 | |
| 17 | How do I manage nocardiosis? Hit paper breakdown → | 2021 | 127 |
| 18 | 2016 | 124 | |
| 19 | 2012 | 124 | |
| 20 | 2013 | 120 |
About Dafna Yahav
Dafna Yahav is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 283 papers that have together received 8.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (42 papers), Antimicrobial Resistance in Staphylococcus (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers), Antibiotic Use and Resistance (19 papers), SARS-CoV-2 and COVID-19 Research (18 papers), Bacterial Identification and Susceptibility Testing (17 papers), COVID-19 Clinical Research Studies (15 papers) and Neutropenia and Cancer Infections (14 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (786 citations), Molecular Medicine (2.1k citations), Microbiology (131 citations), Infectious Diseases (1.9k citations) and Clinical Biochemistry (638 citations). Dafna Yahav has collaborated with scholars based in Israel, Italy and United States. Frequent co-authors include Mical Paul, Leonard Leibovici, Jihad Bishara, Noa Eliakim‐Raz, Abigail Fraser, Benaya Rozen Zvi, Noam Tau, Elad Goldberg, Adi Lador and Henrietta Abodakpi. Their work appears in journals such as Clinical Microbiology and Infection, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Infectious Diseases and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.